Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 6661466)

Published in Biol Psychiatry on December 01, 1983

Authors

E L Gardner, T F Seeger

Articles citing this

Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters. Neuropharmacology (2009) 0.87

Articles by these authors

Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science (2001) 2.97

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) (1990) 1.32

A pharmacologic strategy for the treatment of nicotine addiction. Synapse (1999) 1.27

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci (1995) 1.22

A novel strategy for the treatment of cocaine addiction. Synapse (1998) 1.18

Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science (1991) 1.17

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol (1990) 1.05

The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res (1988) 1.03

Visualization of opiate receptor upregulation by light microscopy autoradiography. Proc Natl Acad Sci U S A (1984) 1.01

Modulation of rat brain opioid receptors by cannabinoids. J Pharmacol Exp Ther (1987) 0.99

Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res (1993) 0.99

Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse (1999) 0.99

3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem (1996) 0.97

(-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse (1997) 0.97

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci (1996) 0.94

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res (1991) 0.92

Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. Proc Natl Acad Sci U S A (1974) 0.91

Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci Lett (1991) 0.90

Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse. J Med Chem (2000) 0.89

The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. Eur J Pharmacol (2001) 0.89

Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment. Life Sci (1983) 0.88

GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. Eur J Pharmacol (2001) 0.88

Naltrexone-induced opiate receptor supersensitivity. Brain Res (1982) 0.87

Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA). Synapse (2000) 0.87

Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther (1985) 0.86

Interaction of [3H](-)-SKF-10,047 with brain sigma receptors: characterization and autoradiographic visualization. J Neurochem (1986) 0.86

In vivo autoradiography: visualization of stress-induced changes in opiate receptor occupancy in the rat brain. Brain Res (1984) 0.86

Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology (Berl) (1982) 0.85

A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats. Neuroscience (2009) 0.85

Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse (2001) 0.83

Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res (1980) 0.83

Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse (1992) 0.83

Acetylmethadol metabolites influence opiate receptors and adenylate cyclase in amygdala. Eur J Pharmacol (1981) 0.81

Self-stimulation pathways in the monkey, Macaca mulatta. Exp Neurol (1971) 0.80

Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligand. J Med Chem (1993) 0.79

In vivo opioid receptor occupation in the rat brain following exercise. Med Sci Sports Exerc (1986) 0.79

The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats. Neuropsychobiology (1997) 0.79

Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: implications for the neural locus of cocaine sensitization. Life Sci (1996) 0.78

Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes. Brain Res (1979) 0.78

Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block. Neurosci Lett (1991) 0.77

Changes in local cerebral glucose utilization during rewarding brain stimulation. Proc Natl Acad Sci U S A (1984) 0.77

Effects of haloperidol on human plasma magnesium. J Psychiatr Res (1993) 0.77

Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions. Eur J Pharmacol (1980) 0.77

Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions. Proc Natl Acad Sci U S A (1987) 0.77

Atypical antipsychotics--recent findings and new perspectives. Med Res Rev (1989) 0.77

Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav (1981) 0.76

Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity. Brain Res (1979) 0.76

Metabolic mapping of the brain during rewarding self-stimulation. Science (1984) 0.76

In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion. Biol Psychiatry (1984) 0.76

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem (1991) 0.76

Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Brain Res (1992) 0.76

Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold. Pharmacol Biochem Behav (1981) 0.75

Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium. Brain Res (1981) 0.75

Opiate receptor upregulation and functional supersensitivity. NIDA Res Monogr (1984) 0.75

Differential effects of chronic haloperidol administration on midbrain dopamine neurons in Sprague-Dawley, Fischer 344, and Lewis rats: an in vivo electrophysiological study. Synapse (1998) 0.75

Mitigation of the septal lesion syndrome by pre-lesion chronic treatment with haloperidol. Pharmacol Biochem Behav (1982) 0.75

Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity. Brain Res (1983) 0.75

GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area. Brain Res (1980) 0.75

Interaction of opiates with dopamine receptors: receptor binding and behavioral assays. Pharmacol Biochem Behav (1982) 0.75

Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. J Med Chem (1990) 0.75

Dopamine agonists induce recovery from surgically-induced septal rage. Nature (1977) 0.75

Modulation of hypothalamic ICSS by concurrent limbic stimulation. Physiol Behav (1974) 0.75

Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclase. Brain Res (1979) 0.75

Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. Eur J Pharmacol (1980) 0.75

ECS dissociation of learning and one-way cross-dissociation with physostigmine and scopolamine. Physiol Behav (1972) 0.75

Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen. Brain Res (1992) 0.75

A method for rapid implantation of several intracranial electrodes. Physiol Behav (1970) 0.75

Similar effects of an enkephalin analog on mesolimbic dopamine release and hyperactivity in rats. Life Sci (1983) 0.75